FIELD: medicine.
SUBSTANCE: claimed invention relates to field of molecular biology, virology and medicine. Claimed is application of adenovirus for manufacturing medication for tumor treatment. Said virus is replication-deficient in cells which do not contain YB-1 in nucleus and encodes oncogenic protein E1A, which transactivates at least one viral gene from group including E1B55kDa, E4orf6, E4orf6 and E3ADP.
EFFECT: invention can be used for treating tumors demonstrating resistance to many cytostatic medications.
19 cl, 19 dwg, 13 ex
Title |
Year |
Author |
Number |
ADENOVIRUS WITH DIRECTED GENE EXPRESSION AND USE THEREOF |
2003 |
|
RU2393221C2 |
TREATMENT OF TUMORS WITH A COMBINATION OF ONCOLYTIC ADENOVIRUS AND CDK4/6 INHIBITOR |
2019 |
- Holm, Per, Sonne
- Nawroth, Roman
|
RU2811278C2 |
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS |
2009 |
- Khemminki Akseli
- Kanerva Anna
- Cherullo Vinchentso
- Pesonen Sari
|
RU2520823C2 |
ADENOVIRUS CONTAINING ALBUMIN-BINDING SITE |
2015 |
- Alemany Bonastre, Ramon
- Rojas Exposito, Luis Alfonso
|
RU2711371C2 |
GENE DELIVERY VECTOR CAPABLE TO INDUCE CELL APOPTOSIS |
1998 |
- Noteborn Mateus Khjubertjus Marija
- Pitersen Aleksandra Marija
|
RU2252255C2 |
ONCOLYTIC ADENOVIRUS FOR TREATING CANCER, USING IT, AND PHARMACEUTICAL COMPOSITION CONTAINING IT |
2010 |
- Gedan Karrio Sonija
- Kaskal'O Pikeras Manel' Marija
- Alemani Bonastre Ramon
|
RU2536931C2 |
NERVOUS SYSTEM CELLS EXPRESSING E4ORF1 OF ADENOVIRUS, AND METHODS FOR THEIR PRODUCTION AND APPLICATION |
2015 |
- Qiang Liang
- Davis Claude Geoffrey
- Nolan Daniel Joseph
|
RU2745300C2 |
RECESSIVE DIVIDING RETROVIRAL VECTOR (VARIANTS), METHOD FOR PRODUCTION THEREOF (VARIANTS), ISOLATED AND PURIFIED NUCLEIC ACID MOLECULE |
1996 |
- Drop'Julik Boro
- Piza Paula M.
|
RU2270250C2 |
IMMORTALISED BIRD CELL LINES FOR OBTAINING VIRUSES |
2004 |
- Zandig Fol'Ker
- Jordan Ingo
|
RU2359999C2 |
RECOMBINANT ONCOLYTIC VIRUS, METHOD FOR ITS PRODUCTION, ITS APPLICATION AND THE DRUG ON ITS BASIS |
2020 |
|
RU2795230C1 |